A lung cancer that changes its identity may be hiding in plain sight
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2026 02:15 ET (23-Jun-2026 06:15 GMT/UTC)
Researchers from the Institute for Systems Biology (ISB) and collaborators show that some lung cancers can change identity as they evolve, forming hybrid cell states and immune-protected regions that may help tumors evade treatment. The findings point to new opportunities for earlier detection and more precise therapies.
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, and resistance to therapy due to their innate capacity for self-renewal and differentiation. Although the molecular mechanisms controlling CSC biology are poorly understood, recent research highlights the pivotal regulatory role of non-coding RNAs—specifically long non-coding RNAs (lncRNAs)—in governing these processes.
In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increase in the risk of lung cancer, mesothelioma, or laryngeal cancer. The findings are published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer. Access the complete study here: https://www.jto.org/article/S1556-0864(26)00163-2/.
A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression in solid tumors. The study summarizes molecular mechanisms of FAK activation and highlights emerging combination therapies and next-generation inhibitors that could reshape future cancer treatment strategies.
Thanks to supercomputing, the research was able to analyze the activity of 20,000 genes in more than one million cells with unprecedented resolution, revealing different aging dynamics between men and women, which will be key to achieving precision medicine.
This study highlights that many characteristics of immune system aging that were previously considered universal actually present specific dynamics according to biological sex.
The organoids make it possible to observe the disease in a slightly more realistic environment, compared to single-layer cell cultures, and to improve drug screening before carrying out clinical trials with patients. The group of researchers has therefore developed organoids from pluripotent stem cells and used them to develop the tumor.
Novel blood-based biomarker predicts cancer risk in patients with Lynch Syndrome
New epigenetic target sensitizes pancreatic tumors to immunotherapy
Promising strategy may help to overcome radiotherapy resistance in lung cancer
High dose radiation therapy improves outcomes for patients with bile duct tumors